Just a few weeks ago on January 15, the Food and Drug Administration (FDA) under the Biden administration revoked authorization of the additive red dye 3, meaning it will be banned from foods and ...

The U.S. Food and Drug Administration has approved Journavx (suzetrigine) 50 milligram oral tablets, marking the introduction of a first-in-class non-opioid analgesic designed to treat moderate to ...

JavaScript is disabled in your web browser or browser is too old to support JavaScript. Today almost all web pages contain JavaScript, a scripting programming language that runs on visitor's web ...

It is critical that agencies mandated to protect public health, such as the Food and Drug Administration (FDA), maintain their authority to ensure these products meet high safety standards that ...

It's a vital part of brand identity and makes an instant impression. An emblem logo fuses visuals and text to convey what a company stands for in a memorable way. Rather than just spelling out a name, ...

The Food and Drug Administration announced it would decide by April 2024 whether chemical hair straightening products sold in the U.S. would be banned from using formaldehyde or ingredients that ...

Agencies subject to the HHS directive include the CDC, the National Institutes of Health and the Food and Drug Administration — entities that fight epidemics, protect the nation's food supply ...

However, it had to be used in conjunction with an oral medication. The FDA has now expanded its approval to include the standalone use of the nasal spray for adults with treatment-resistant major ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...

Note: We’re tracking these changes closely and will update this piece as new developments emerge. Please feel free to reach out and share feedback or flag additional areas for review. 2025 marks ...

Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...